Scientific & Professional Training
Comprehensive Pneumology Center
Our Mission - Creating a unique structured translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science.
Donovan Correa-Gallegos, member of the CPC Research School, successfully defended his thesis "Ontological and anatomical origin of cutaneous...
Pushkar Ramesh, member of the CPC Research School successfully defended his thesis "Following fibroblast lineages in dermal development and scars" on...
Stefanie Weiß, member of the CPC Research School successfully defendet her thesis "Differential subclass pathogenicity of antibodies in a mouse model...
The CPC Career Day is an event that is thought to give doctoral candidates a glimpse into various career options after their PhD. The students gain...
Lena Haist, doctoral student at Anne Hilgendorffs' group at the Institute of Lung Biology and Diseases (ILBD) and the Comprehensive Pneumology Center...
The MD/PhD Program at the Comprehensive Pneumology Center (CPC) aims to create a unique translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science.
The program benefits from its supporting partners - the Helmholtz Zentrum München - German Research Center for Environmental Health - and the Ludwig-Maximilians-University and the university hospital system - thereby providing an excellent and inspiring environment for translational research.
Moreover, the Spokesperson, PD Dr. Claudia Staab-Weijnitz, and Program Coordinator, Karin Herbert, are supported by an advisory board that includes representatives of all main stakeholders from the Institute of Lung Biology and Disease, Research Unit Lung Repair and Regeneration, and Institute of Epidemiology at the Helmholtz Zentrum München.
(Clinician-)Scientists trained within the program have diverse career options in the expanding biomedical field, and will undoubtedly be able to advance our understanding of lung disease and develop novel therapies for improving the care and quality of life of patients suffering from lung disease.